Clinical Trials Browser

CX 5461 × Tumor-Agnostic × 90 days × Clear all

NCT06606990 2026-03-18

Testing How the Body Responds to the Drug CX-5461 (Pidnarulex) in Patients With Metastatic Solid Cancers

Phase 1 Recruiting

Neoplasm Metastasis